A Phase II Study of Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Latest Information Update: 17 Mar 2025
At a glance
- Drugs Belinostat (Primary) ; Binimetinib (Primary)
- Indications Uveal melanoma
- Focus Therapeutic Use
Most Recent Events
- 13 Mar 2025 Planned primary completion date changed from 1 Sep 2025 to 1 Jan 2027.
- 13 Feb 2025 Planned End Date changed from 1 Dec 2025 to 1 Jan 2028.
- 12 Dec 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.